Article
<i>TP53</i> -mutant AML with ribosomal gene loss exhibits impaired protein translation and sensitivity to HSP90 inhibition
2025-10-02
Abstract excerpt
TP53 -mutated acute myeloid leukemia (AML) represents a particularly aggressive and therapeutically refractory subtype of the disease. While recurrent chromosomal abnormalities such as -5/del(5q), -7/del(7q), and del(17p) are well studied in this context, additional co-occurring events remain less well defined. Using the multi-dimensional Leucegene dataset (∼700 primary AML specimens), we identified and comprehens...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 42d4543b-e2d6-580c-b06d-4de6ba66239e
- DOI
- 10.1101/2025.10.01.679539
